Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice

AIMS: In post‐menopausal women, incidence of heart failure with preserved ejection fraction is higher than in men. Hormonal replacement therapies did not demonstrate benefits. We tested whether the non‐steroidal mineralocorticoid receptor antagonist finerenone limits the progression of heart failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Pieronne‐Deperrois, Marie, Guéret, Alexandre, Djerada, Zoubir, Crochemore, Clément, Harouki, Najah, Henry, Jean‐Paul, Dumesnil, Anaïs, Larchevêque, Marine, do Rego, Jean‐Claude, do Rego, Jean‐Luc, Nicol, Lionel, Richard, Vincent, Jaisser, Frédéric, Kolkhof, Peter, Mulder, Paul, Monteil, Christelle, Ouvrard‐Pascaud, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120350/
https://www.ncbi.nlm.nih.gov/pubmed/33742556
http://dx.doi.org/10.1002/ehf2.13219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120350/
https://www.ncbi.nlm.nih.gov/pubmed/33742556
http://dx.doi.org/10.1002/ehf2.13219

Ejemplares similares